SKI Market

A+| A| A-|

Indian Indices

Sensex

75,237.99 -160.73
( -0.21%)

Global Indices

Nasdaq

49,543.85 -540.61
(-1.08%)

Dow Jones

7,428.26 -93.98
(-1.25%)

Hang Seng

61,141.50 -1,512.55
(-2.41%)

Nikkei 225

10,172.40 -200.53
(-1.93%)

Forex

USD-INR

95.71 0.07
(0.07%)

EUR-INR

111.93 -0.13
(-0.12%)

GBP-INR

129.01 -0.31
(-0.24%)

JPY-INR

0.61 0.00
(-0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Deep Health AI India Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

539559

INE005G01026

2.4513632

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

5.42

33.59

EPS(TTM)

Face Value()

Div & Yield %

0.43

Back

modern engineering & projects limited

Syncom Formulations (India) consolidated net profit rises 45.46% in the December 2025 quarter

Feb 12,2026

Net profit of Syncom Formulations (India) rose 45.46% to Rs 18.91 crore in the quarter ended December 2025 as against Rs 13.00 crore during the previous quarter ended December 2024. Sales declined 9.72% to Rs 115.14 crore in the quarter ended December 2025 as against Rs 127.53 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	115.14	127.53	-10
OPM %	18.42	11.55	-
PBDT	26.45	18.57	42
PBT	25.09	17.26	45
NP	18.91	13.00	45

75,237.99 -160.73 ( -0.21%)

49,543.85 -540.61 (-1.08%)

7,428.26 -93.98 (-1.25%)

61,141.50 -1,512.55 (-2.41%)

10,172.40 -200.53 (-1.93%)

95.71 0.07 (0.07%)

111.93 -0.13 (-0.12%)

129.01 -0.31 (-0.24%)

0.61 0.00 (-0.09%)